Activists Condemn Gilead for Exhorbitant Price of Their New Hepatitis C Drug

<!--[if gte vml 1]> <![endif]--><!--[if !vml]--><!--[endif]--> For Immediate Release December 9, 2013 Contact: Lynda Dee 410-332-1170 or lyndamdee@aol.com Fair Pricing Coalition Condemns Gilead Sciences on the High Price of New Hepatitis C Drug Sovaldi™, and Urges Rapid and Wide Dissemination of Support Program Details for
Source: Nelson Vergel's HIV Blog - Category: HIV AIDS Authors: Source Type: blogs